American Trust Insulet Corp Transaction History

American Trust

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 21, 2024	BUY	$127.77 - $221.42 $124,320 - $215,441	973 New	973 $211,000
Q2 2023 Aug 14, 2023	SELL	$272.48 - $330.23 $101,090 - $122,515	-371 Reduced 22.39%	1,286 $370,000
Q1 2023 May 22, 2023	SELL	$276.36 - $326.03 $92,856 - $109,546	-336 Reduced 16.86%	1,657 $528,000
Q4 2022 Feb 16, 2023	SELL	$212.22 - $313.46 $44,566 - $65,826	-210 Reduced 9.53%	1,993 $586,000
Q3 2022 Dec 02, 2022	SELL	$224.6 - $281.45 $11,903 - $14,916	-53 Reduced 2.35%	2,203 $505,000
Q2 2022 Oct 03, 2022	SELL	$186.4 - $279.02 $24,604 - $36,830	-132 Reduced 5.53%	2,256 $492,000
Q1 2022 Jun 08, 2022	SELL	$194.8 - $275.7 $27,661 - $39,149	-142 Reduced 5.61%	2,388 $636,000
Q4 2021 Mar 17, 2022	BUY	$255.32 - $318.29 $645,959 - $805,273	2,530 New	2,530 $673,000

659

63.5M

385K

773K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $16.2B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.